GRCU Recent activities 08/27/2014 23:21:02 $GRCU Lets get

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
GRCU Recent activities 08/27/2014 23:21:02 $GRCU
Lets get green tomorrow.....
The attorney letter is by Richard "Dick" Weed. What do we know about this attorney? It seems an odd/fictitious name. Holding strong still, but somewhat skeptical of the attorney letter.

GRCU Stock Message Board http://investorshangout.com/Green-Cures-and-B...RCU-67874/

Let’s Talk About Federal Marijuana Legalization
BY MIKE ADAMS · FRI AUG 01, 2014

Some lawmakers predict marijuana will be legal on a federal level within five to ten years. Although, when it happens, there is a distinct possibility the law will not translate into Americans enjoying a fully legalized recreational market. There is a greater chance it will be a piece of three-legged legislation giving only patients with legitimate medical conditions access to cannabis.

Now, there is an entire legion of marijuana advocates out there that would be satisfied with this toe-in-the-water approach to repealing federal prohibition, but many others, myself included, will not be satisfied with pussy fist legislation that puts weed under the thumb of a loosely amended version of the Controlled Substances Act.

The people of this country deserve the right to legally unwind with marijuana just as the majority has done for decades with alcohol. And while it may be simple enough for a healthy individual to walk into a clinic and convince a physician that he or she is in need of medical marijuana, most of us would rather not have to go through the hassle to simply catch a buzz.

The truth is, the only way legalized marijuana is ever going work in this country is if it is completely removed from the confines of the Controlled Substances Act and federally regulated under the same government agency that currently has the leashes on beer and cigarettes -- rename it the Alcohol, Cannabis and Tobacco Tax and Trade Bureau.

You may not be aware of this, but there is a bill lingering in the halls of Congress called the “Ending Federal Marijuana Prohibition Act of 2013,” which would end pot prohibition and establish a fully legalized cannabis trade here in America. Unfortunately, the proposal has not received any support since Colorado Representative Jared Polis submitted it back in early 2013, and it is doubtful the bill has any realistic chance at being considered anytime in the near future. Perhaps this is the reason many pot proponents have argued, “it will take an act of Congress” before marijuana has a chance at achieving legal status in the United States.

However, there appears to be some confusion about who actually has the authority to make changes to the nation’s pot laws. Most argue that the state of legal weed in America absolutely hangs by the short-and-curlies of Congress, while others assert the Obama Administration has the power to cut the legs off prohibition as early as today.

In an interview that took place earlier this year with CNN’s Jake Tapper, President Obama himself said it was up to Congress, not the Drug Enforcement Administration, to decide whether or not to reclassify cannabis. The next day, drug policy experts lashed out against the president for failing to take responsibility for maintaining prohibition in America. “While Congress can amend the Controlled Substances Act (CSA) to increase or reduce restrictions on particular drugs, the statute also gives that power to the attorney general, who has delegated it to the Drug Enforcement Administration (a division of the Justice Department),” wrote Jacob Sullum, senior editor at Reason Magazine. “In fact, the DEA has repeatedly rejected petitions to reschedule marijuana, most recently in 2011. I forget: Who was president then?”

UCLA Professor of Public Policy, Mark Kleiman recently told New York Magazine that one of the most important moves President Obama could make right now is initiating changes to the National Institute on Drug Abuse and the Drug Enforcement Administration that would make it easier for scientists to receive approval for marijuana research. "Every fourteen-year-old boy has access to better pot than any research scientist,” he said.

Of course, in order to open the doors for researchers, the president would first have to make the decision to downgrade marijuana’s Schedule I classification, which he clearly has the authority to jumpstart.

Unfortunately, we do not expect the president to roll up his sleeves and make any significant changes before leaving the Oval Office. Especially, not after the White House issued a statement this week, in response to The New York Times article “Repeal Prohibition, Again,” in which the Obama Administration wrote that it would not legalize marijuana because increased access would lead to an onslaught of public health problems.

(Photo: Alex Wong/Getty Images)

Mike Adams writes for stoners and smut enthusiasts in High Times, Playboy’s The Smoking Jacket and Hustler Magazine. You can follow him on Twitter @adamssoup and on Facebook/mikeadams73.

#GRCU
Does this mean the yield sign is coming off?
Report | August 25, 2014

Washington's Marijuana Legalization Grows Knowledge, Not Just Pot

By: Philip A. Wallach

Share on emailShare on twitterShare on facebookShare on linkedin Share on google_plusone_shareShare on stumbleuponShare on redditShare on print
Voters in Washington state decided in November 2012 to legalize marijuana in their state, inspired by a campaign that emphasized minimizing the drug’s social costs and tightly controlling the legal recreational market. Joined to this drug policy experiment is a second innovative experiment that emphasizes knowledge: the state will fund and develop tools necessary to understand the impact of legalization on Washington’s law enforcement officials, communities, and public health.

This second reform, though less heralded than the attention-grabbing fact of legalization, is in many ways just as bold. Washington’s government is taking its role as a laboratory of democracy very seriously, tuning up its laboratory equipment and devoting resources to tracking its experiment in an unusually meticulous way, with lessons that extend well beyond drug policy.


“Regulators, like the lay public, will think more clearly about an issue when they are informed by a steady stream of relatively rigorous data and findings.”
Brookings’ Philip Wallach interviewed advocates, researchers, and government policymakers in Washington to learn about the state’s novel approach. In this report, he highlights several noteworthy features:

Building a funding source for research directly into the law: a portion of the excise tax revenues from marijuana sales will fund research on the reform’s effects and on how its social costs can be effectively mitigated.
Bringing to bear many perspectives on legalization by coordinating research efforts across multiple state agencies, including the Department of Social and Health Services, the Department of Health, and the Liquor Control Board.
Mandating a cost-benefit analysis by the state’s in-house think tank, which will be nearly unprecedented in its scope and duration.
Wallach makes a number of suggestions to ensure that Washington’s knowledge experiment can be made to work, including:

Ensure political independence for researchers, both by pressuring politicians to allow them to do their work and by encouraging the researchers themselves to refrain from making political recommendations
Gather and translate research into forms usable by policymakers
Counter misinformation with claims of confident uncertainty
Have realistic expectations about the timeline for empirical learning, which means cultivating patience over the next few years
Specify which reliable metrics would indicate success or failure of legalization

“While Colorado is justifiably garnering headlines with its ambitiously rapid (and, in many respects, impressive) legalization rollout, there is a case to be made that Washington is undertaking the more radical and far-reaching reform.”
I will be buying at some point tomorrow, probably another $2,000 worth. $grcu

Absolutely! Perhaps the ride of a lifetime!!!

#GRCU
Anybody buying more shares Thursday ? Honest answers only please. Most likely there will be a small gap up in the morning I think.
GRCU!!!<----GOING PLACES !!
Best Post To Date: GRCU, thanks onpoint

onpoint2 Member Level Wednesday, 08/27/14 10:14:12 PM
Re: GM_Tech post# 169684
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nuvini Group Limited Achieves Remarkable Growth in 2024

Updated Category News Views 242

Outstanding Financial Performance Delivered by Nuvini Group NEW YORK — Nuvini Group Limited (Nasdaq: NVNI) has released its financial results for the first half of 2024, demonstrating impressive growth across various metrics. The company continues to set the bar high in the realm of private SaaS B2B acquisitions in Latin America. Growth Metrics Highlight Success The...

Continue Reading
MarketFully Expands Reach with Social Element Acquisition

Updated Category News Views 168

MarketFully Enhances Capabilities with New Acquisition Markfully, the leader in InContent Marketing, has broadened its horizons through the acquisition of a prominent global social media agency, Social Element. This strategic move is set to amplify MarketFully's capacity for delivering multilingual content marketing solutions, particularly across social media platforms....

Continue Reading
Lone Star Family Health Center Partners with athenahealth to Enhance Patient Care

Updated Category News Views 717

Lone Star Family Health Center Partners with athenahealth for Enhanced Care Lone Star Family Health Center (LSFHC), a notable health service provider, has made a major decision to transition to athenaOne, a cutting-edge suite of medical software. This strategic move aims to elevate patient care experiences and health outcomes substantially. athenahealth, well-known for...

Continue Reading
Promising Long-Term Results for Zeposia in Multiple Sclerosis

Updated Category News Views 123

Zeposia (ozanimod): A Breakthrough in Multiple Sclerosis Treatment Bristol Myers Squibb has recently shared compelling long-term findings from the Phase 3 DAYBREAK trial on Zeposia (ozanimod). This promising oral treatment has proven effective in managing relapsing forms of multiple sclerosis (MS). The results underscore Zeposia's sustained effectiveness and safety, which...

Continue Reading
Encompass Health Expands Its Rehabilitation Services in Florida

Updated Category News Views 268

Encompass Health Opens New Rehabilitation Hospital Encompass Health has recently made a significant impact in the healthcare landscape by launching a new facility. The Encompass Health Rehabilitation Hospital of St. Petersburg is now officially open to patients, marking the company's 25th location in Florida. Quality Care for Patients This facility is aimed at improving...

Continue Reading